| NCT | Trial Name | # of Centers |
|---|
NCT02523014 |
A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas | 340 |
NCT02796261 |
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients | 77 |
NCT02320058 |
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself | 35 |
NCT02052778 |
A Study of TAS-120 in Patients With Advanced Solid Tumors | 28 |
NCT02639546 |
iMATRIXcobi: Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients With Previously Treated Solid Tumors | 24 |
NCT02048059 |
ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases | 17 |
NCT02798406 |
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects | 13 |
NCT02658279 |
Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype | 11 |
NCT01494662 |
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | 11 |
NCT02026271 |
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma | 6 |
NCT02880410 |
Feasibility Study on LITT for Newly Diagnosed Glioblastoma | 4 |
NCT03215511 |
Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers | 4 |
NCT02576665 |
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) | 3 |
NCT01295944 |
Carboplatin and Bevacizumab for Recurrent Ependymoma | 3 |
NCT01063114 |
Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma | 2 |
NCT02340156 |
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma | 2 |
NCT02693990 |
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas | 2 |
NCT02626364 |
Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification | 1 |
NCT02254954 |
Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed GBM. | 1 |
NCT01499251 |
Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma | 1 |
